Pfizer Collaborates with Beam on Gene Editing Technology

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)

Published: 20 Jan-2022

DOI: 10.3833/pdr.v2022.i1.2656     ISSN: 1756-7874

Section: Research & Development



Starting 2022 in earnest, Pfizer has agreed to collaborate with Beam Therapeutics to develop gene editing therapies for rare genetic diseases of the liver, muscle, and central nervous system...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details